.
BioEnterprise

How we grow companies

We provide

  • Access to bioscience venture capital, private equity and grant funding opportunities
  • Privileged relationships with world-class research and clinical institutions
  • Experienced bioscience management guidance
  • A network of technical services, equipment, professional service providers, and flexible development space
  • Business development and alliance support for strategic partnerships
  • Strategic marketing and communications guidance

With our partners, we have

  • Created, recruited and accelerated more than 350 companies
  • Helped these companies raise more than $2 billion in new funding
  • Assisted in 540+ technology transfer deals concluded with industry partners
  • Evaluated over 1,900 company opportunities and 3,400 invention disclosures
  • Expanded or relocated 60+ biomedical companies to Cleveland

Perspectives on building a bioscience company »

What We Seek

Secrets of Successful Biomedical Companies

Team BioEnterprise

We like to partner with start-ups that:

Offer a strong value proposition, uniquely solving specific customer pain points through IP-protected products, services or therapies;

Operate in big markets, and/or in markets on a trajectory for fast growth;

Are properly capitalized, with the right investment mix at the right time;

Make their own luck by adapting their business models and plans to the changing circumstances and complexities of the healthcare system;

Develop viable reimbursement strategies to ensure appropriate coding, coverage and payment for the technology or service provided;

Are led by entrepreneurs who are coachable, willing to listen, learn, teach, partner, and bring in new advisors and leadership appropriate to different stages of company growth;

Are managed by teams who are experienced, flexible, focused, nimble, reflexive, resilient, smart and tenacious.

 

Close
Point of View

From the Experts

Record Number of Midwest Healthcare Startups Raise $1.7 Billion in 2016

Aram Nerpouni
As a sign of the Midwest’s continued growth as an engine of biomedical commercialization, a record 375 Midwest healthcare companies raised $1.7 billion in 2016, the second largest amount recorded.

Unlocking the Door to Hospital Sales

Vijay Iyer, Ph.D.
Gatekeepers, as with many organizations, control access to hospital purchasers, and that control brings both great power and great responsability. Hospital purchasing gatekeepers are officially known as the value analysis…

Why Invest Here? Healthcare and Biotech Success in Northeast Ohio

Tim Miller, Ph.D.
I’m the president and CEO of a publicly traded bioscience company who recently decided to locate and expand my company, Abeona Therapeutics, in Northeast Ohio instead of any other state or region

Close
Feature

In-depth Examinations

Growth After Acquisition … in Cleveland

Aram Nerpouni, President and CEO, BioEnterprise
The acquisition by medtech giant Medtronic is making it possible for CardioInsight to commercialize its breakthrough patented electrocardiographic imaging technology that will significantly improve the diagnosis and treatment of a number of critical heart conditions.

Close